Form 4: Prestige Consumer Healthcare Executive Reports Stock Transactions

Mary Beth Fritz, SVP of Quality & Regulatory at Prestige Consumer Healthcare, reports acquisition and disposal of company stock following vesting of performance stock units.

Summary

• On May 6, 2024, Mary Beth Fritz, SVP of Quality & Regulatory at Prestige Consumer Healthcare Inc., reported transactions involving the company's common stock.
• Fritz acquired 3,456 shares of common stock at $0, representing the settlement of performance stock units (PSUs) granted on May 3, 2021, which vested based on achievement of adjusted earnings per share growth goals.
• Concurrently, Fritz disposed of 1,597 shares at $70 to cover tax obligations, resulting in a net holding of 16,793 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation. The vesting of PSUs is a positive sign, but the sale of shares to cover taxes is a common practice and doesn't necessarily indicate a negative outlook.

Positives

• The vesting of performance stock units indicates that the company has met certain adjusted earnings per share growth targets.

Negatives

• The disposal of shares to cover tax obligations could be interpreted as a slightly negative signal, although it is a common practice.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's confidence in the company's prospects.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their executives.
• The transactions reported are typical for executives receiving and vesting stock-based compensation.

Stakeholder Impact

• The transactions have a minor impact on shareholders, as they involve a relatively small number of shares.
• Employees may view the vesting of PSUs as a positive sign of the company's performance.

Key Dates